Showing results (1461-1470 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 30, 2016
Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerMeghan Campo, Hani Al-Halabi, Melin Khandekar, et al.
The Oncologist|October 30, 2015
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?Richard M Goldberg
The Oncologist|October 30, 2015
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21Hyo Jung Kim, Sang Won Shin, Eun-Kee Song, et al.
The Oncologist|November 7, 2015
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate CancerUrban Emmenegger, Christopher M Booth, Scott Berry, et al.
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
The Oncologist|October 19, 2013
Breast cancer multifocality and multicentricity and locoregional recurrenceSiobhan P Lynch, Xiudong Lei, Limin Hsu, et al.
The Oncologist|November 18, 2011
Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approvalMartin H Cohen, John R Johnson, Robert Justice, et al.
The Oncologist|February 25, 2012
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group StudyJavier Sastre, Cristina Grávalos, Fernando Rivera, et al.
The Oncologist|May 25, 2012
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapyTakahiro Tsushima, Masataka Taguri, Yoshitaka Honma, et al.
The Oncologist|May 25, 2012
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinomaWen-Yi Shau, Yu-Yun Shao, Yi-Chun Yeh, et al.
Pageof 571